These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 20975337)

  • 21. [Clinicopathologic features of kaposiform hemangioendothelioma].
    Tang HF; Zhou YY; Gu WZ; Li MJ
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(18):1132-5. PubMed ID: 15498303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dilated lymphatic vessels in tufted angioma: a potential source of diagnostic confusion.
    Sadeghpour M; Antaya RJ; Lazova R; Ko CJ
    Am J Dermatopathol; 2012 Jun; 34(4):400-3. PubMed ID: 22307233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of hemangiomas and other vascular tumors.
    Greene AK
    Clin Plast Surg; 2011 Jan; 38(1):45-63. PubMed ID: 21095471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-level expression of podoplanin in benign and malignant soft tissue tumors: immunohistochemical and quantitative real-time RT-PCR analysis.
    Xu Y; Ogose A; Kawashima H; Hotta T; Ariizumi T; Li G; Umezu H; Endo N
    Oncol Rep; 2011 Mar; 25(3):599-607. PubMed ID: 21234520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kaposiform hemangioendothelioma and tufted angioma - (epi)genetic analysis including genome-wide methylation profiling.
    Ten Broek RW; Koelsche C; Eijkelenboom A; Mentzel T; Creytens D; Vokuhl C; van Gorp JM; Versleijen-Jonkers YM; van der Vleuten CJ; Kemmeren P; van de Geer E; von Deimling A; Flucke U
    Ann Diagn Pathol; 2020 Feb; 44():151434. PubMed ID: 31887709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tacrolimus ointment for the treatment of superficial kaposiform hemangioendothelioma and tufted angioma.
    Zhang X; Yang K; Chen S; Ji Y
    J Dermatol; 2019 Oct; 46(10):898-901. PubMed ID: 31373046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.
    Nguyen VA; Kutzner H; Fürhapter C; Tzankov A; Sepp N
    Mod Pathol; 2006 Feb; 19(2):291-8. PubMed ID: 16424896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
    Hornick JL; Fletcher CD
    Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of angiogenic markers in oral hemangiomas and pyogenic granulomas.
    Freitas TM; Miguel MC; Silveira EJ; Freitas RA; Galvão HC
    Exp Mol Pathol; 2005 Aug; 79(1):79-85. PubMed ID: 16005715
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifocal lymphangioendotheliomatosis with thrombocytopenia: a newly recognized clinicopathological entity.
    North PE; Kahn T; Cordisco MR; Dadras SS; Detmar M; Frieden IJ
    Arch Dermatol; 2004 May; 140(5):599-606. PubMed ID: 15148106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Histopathology of vascular lesions found in Kasabach-Merritt syndrome: review based on 13 cases.
    Alvarez-Mendoza A; Lourdes TS; Ridaura-Sanz C; Ruiz-Maldonado R
    Pediatr Dev Pathol; 2000; 3(6):556-60. PubMed ID: 11000333
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Vascular tumors and pseudo-tumors. Spindle-cell hemangioma].
    Wassef M
    Ann Pathol; 2011 Aug; 31(4):271-5. PubMed ID: 21839351
    [No Abstract]   [Full Text] [Related]  

  • 33. Kaposiform hemangioendothelioma: a study of 33 cases emphasizing its pathologic, immunophenotypic, and biologic uniqueness from juvenile hemangioma.
    Lyons LL; North PE; Mac-Moune Lai F; Stoler MH; Folpe AL; Weiss SW
    Am J Surg Pathol; 2004 May; 28(5):559-68. PubMed ID: 15105642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of lymphatic endothelium in pediatric vascular tumors and malformations.
    Galambos C; Nodit L
    Pediatr Dev Pathol; 2005; 8(2):181-9. PubMed ID: 15719202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retiform hemangioendotheliomas usually do not express D2-40 and VEGFR-3.
    Parsons A; Sheehan DJ; Sangueza OP
    Am J Dermatopathol; 2008 Feb; 30(1):31-3. PubMed ID: 18212541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular tumors and vascular malformations: evidence for an association.
    Garzon MC; Enjolras O; Frieden IJ
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):275-9. PubMed ID: 10642685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Congenital tufted angioma: Case report and review of the literature.
    Alberola FT; Betlloch I; Montero LC; Nortes IB; Martínez NL; Paz AM
    Dermatol Online J; 2010 May; 16(5):2. PubMed ID: 20492819
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracranial kaposiform hemangioendothelioma: proposal of a new malignant variant.
    Cho WS; Kim SK; Park SH; Cho BK
    J Neurosurg Pediatr; 2009 Feb; 3(2):147-50. PubMed ID: 19278316
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.
    Fiedler U; Christian S; Koidl S; Kerjaschki D; Emmett MS; Bates DO; Christofori G; Augustin HG
    Am J Pathol; 2006 Mar; 168(3):1045-53. PubMed ID: 16507917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inconsistent immunohistochemical expression of lymphatic and blood endothelial cell markers in cutaneous lymphangiomas.
    Bhawan J; Silva C; Taungjaruwinai WM
    J Cutan Pathol; 2013 Sep; 40(9):801-6. PubMed ID: 23782346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.